Mehta Bm

High-dose methotrexate with citrovorum factor rescue: predictive value of serum methotrexate concentrations and corrective measures to avert toxicity.

Anita Nirenberg, Crisanta Mosende, Mehta Bm et al. · PubMed · 1977 · 123 citations

Pharmacology, Toxicology Testing, Citrovorum Factor Rescue +7

High-dose methotrexate with citrovorum factor rescue for the treatment of central nervous system tumors in children.

Gerald Rosen, Fereshteh Ghavimi, Anita Nirenberg et al. · PubMed · 1977 · 65 citations

Surgical Oncology, Mtx Levels, High-grade Gliomas +18

Serum distribution of citrovorum factor and 5-methyltetrahydrofolate following oral and im administration of calcium leucovorin in normal adults.

Mehta Bm, Gisolfi Al, Hutchison Dj et al. · Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) · 1978 · 35 citations

Normal Adults, Pharmacology, Clinical Nutrition +4

Osteogenic sarcoma: eight-percent, three-year, disease-free survival with combination chemotherapy (T-7).

G Rosen, Anita Nirenberg, Brenda Caparros et al. · PubMed · 1981 · 35 citations

Hdmtx Treatments, Bone Disease, Surgical Oncology +13

Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor).

H. Juergens, Cynthia Kosloff, Anita Nirenberg et al. · PubMed · 1981 · 21 citations

Prognostic Factors, Surgical Oncology, Pathology +17